These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24480244)

  • 41. Clinical decisions. Testosterone-replacement therapy.
    Swerdloff R; Anawalt BD
    N Engl J Med; 2014 Nov; 371(21):2032-4. PubMed ID: 25409377
    [No Abstract]   [Full Text] [Related]  

  • 42. The effect of androgens on lipids.
    Monroe AK; Dobs AS
    Curr Opin Endocrinol Diabetes Obes; 2013 Apr; 20(2):132-9. PubMed ID: 23422242
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Androgen deficiency in aging and metabolically challenged men.
    Shelton JB; Rajfer J
    Urol Clin North Am; 2012 Feb; 39(1):63-75. PubMed ID: 22118346
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of hypogonadism in men with chronic kidney disease.
    Johansen KL
    Adv Chronic Kidney Dis; 2004 Oct; 11(4):348-56. PubMed ID: 15492971
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of long-acting testosterone undecanoate on bone mineral density in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 36 months controlled study.
    Aversa A; Bruzziches R; Francomano D; Greco EA; Fornari R; Di Luigi L; Lenzi A; Migliaccio S
    Aging Male; 2012 Jun; 15(2):96-102. PubMed ID: 22439807
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life.
    Malkin CJ; Pugh PJ; Morris PD; Kerry KE; Jones RD; Jones TH; Channer KS
    Heart; 2004 Aug; 90(8):871-6. PubMed ID: 15253956
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Late-onset hypogonadism in men: uncertain disease entity and reservations regarding treatment with testosterone].
    Nieuwenhuijzen Kruseman AC
    Ned Tijdschr Geneeskd; 2006 Sep; 150(35):1925-8. PubMed ID: 16999276
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Comparison of the effect of methyltestosterone and testosterone undecanoate in substitution therapy of hypogonadism].
    Hána V; Marek J; Mellanová A; Hampl R; Stárka L
    Cas Lek Cesk; 1987 Mar; 126(12):369-73. PubMed ID: 3555827
    [No Abstract]   [Full Text] [Related]  

  • 49. 'Andropause'--are reduced androgen levels in aging men physiologically important?
    Matsumoto AM
    West J Med; 1993 Nov; 159(5):618-20. PubMed ID: 8279174
    [No Abstract]   [Full Text] [Related]  

  • 50. Influence of radical prostatectomy on serum hormone levels.
    Miller LR; Partin AW; Chan DW; Bruzek DJ; Dobs AS; Epstein JI; Walsh PC
    J Urol; 1998 Aug; 160(2):449-53. PubMed ID: 9679896
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Testosterone administration in older men.
    Matsumoto AM
    Endocrinol Metab Clin North Am; 2013 Jun; 42(2):271-86. PubMed ID: 23702401
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Testosterone replacement therapy: take an informed, individualized approach.
    Coplan B; Spiegel J; Bleaman I; Roch J
    JAAPA; 2011 Jan; 24(1):42-7. PubMed ID: 21261147
    [No Abstract]   [Full Text] [Related]  

  • 53. Androgens and aging men.
    Baulieu EE
    Mol Cell Endocrinol; 2002 Dec; 198(1-2):41-9. PubMed ID: 12573813
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Medical Treatment of Hypogonadism in Men.
    Mani SB; Clavijo RI
    Urol Clin North Am; 2022 May; 49(2):197-207. PubMed ID: 35428426
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Androgens, estrogens, and bone in men.
    Swerdloff RS; Wang C
    Ann Intern Med; 2000 Dec; 133(12):1002-4. PubMed ID: 11119403
    [No Abstract]   [Full Text] [Related]  

  • 56. The multiple actions of testosterone in men: nature knows best.
    Funder JW
    Asian J Androl; 2014; 16(2):266-7. PubMed ID: 24385014
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Is there a pharmacotherapy for libido disturbances in men?].
    Köhn FM
    Urologe A; 2006 Aug; 45(8):999-1001. PubMed ID: 16832642
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Commentary: Guideline for male testosterone therapy: a clinician's perspective.
    Morgentaler A
    J Clin Endocrinol Metab; 2007 Feb; 92(2):416-7. PubMed ID: 17284642
    [No Abstract]   [Full Text] [Related]  

  • 59. Commentary: Guideline for male testosterone therapy: a regulatory perspective.
    Shames D; Gassman A; Handelsman H
    J Clin Endocrinol Metab; 2007 Feb; 92(2):414-5. PubMed ID: 17284641
    [No Abstract]   [Full Text] [Related]  

  • 60. Commentary: Guideline for male testosterone therapy: a European perspective.
    Wu FC
    J Clin Endocrinol Metab; 2007 Feb; 92(2):418-9. PubMed ID: 17284643
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.